288 related articles for article (PubMed ID: 21883371)
41. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
Peng J; He S; Yang X; Huang L; Wei J
Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
[TBL] [Abstract][Full Text] [Related]
42. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
[TBL] [Abstract][Full Text] [Related]
44. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
45. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
[TBL] [Abstract][Full Text] [Related]
46. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature.
Xie W; Zhao Y; Cao L; Huang W; Wang Y; Huang H
Med Oncol; 2012 Dec; 29(4):2417-22. PubMed ID: 22476762
[TBL] [Abstract][Full Text] [Related]
48. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
49. Congenital blastic plasmacytoid dendritic cell neoplasm.
Yang CS; Wang J; Chang TK
Pediatr Blood Cancer; 2012 Jan; 58(1):109-10. PubMed ID: 21744480
[No Abstract] [Full Text] [Related]
50. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.
Hashikawa K; Niino D; Yasumoto S; Nakama T; Kiyasu J; Sato K; Kimura Y; Takeuchi M; Sugita Y; Hashimoto T; Ohshima K
J Am Acad Dermatol; 2012 Feb; 66(2):278-91. PubMed ID: 21835496
[TBL] [Abstract][Full Text] [Related]
53. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
54. [Blastic plasmacytoid dendritic cell neoplasm: two cases report and review of literatures].
An G; Qi JY; Zou DH; Zhao YZ; Chen HS; Qiu LG
Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):189-92. PubMed ID: 19576083
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous blastic plasmacytoid dendritic cell neoplasm associated with anaemia and thrombocytopaenia.
Prystupa A; Wojnowska D; Skomra D; Borowiec M; Puźniak A; Lachowska-Kotowska P; Ozankaya C; Mayar A; Mosiewicz J; Chodorowska G
Acta Derm Venereol; 2009 Nov; 89(6):646-8. PubMed ID: 19997703
[No Abstract] [Full Text] [Related]
56. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?
Petrella T; Facchetti F
Autoimmunity; 2010 Apr; 43(3):210-4. PubMed ID: 20166873
[TBL] [Abstract][Full Text] [Related]
57. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
An HJ; Yoon DH; Kim S; Shin SJ; Huh J; Lee KH; Suh C
Ann Hematol; 2013 Mar; 92(3):351-6. PubMed ID: 23135479
[TBL] [Abstract][Full Text] [Related]
58. Childhood blastic plasmacytoid dendritic cell neoplasm treated with allogenic stem cell transplantation.
Gambichler T; Pantelaki I; Stücker M
Pediatr Dermatol; 2013; 30(1):142-4. PubMed ID: 22300352
[TBL] [Abstract][Full Text] [Related]
59. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
[TBL] [Abstract][Full Text] [Related]
60. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
